FGF23 and hyperphosphatemia: This leads to a further compensatory increase in FGF-23 levels which fails to exert its phosphaturic and PTH-suppressing effects without Klotho [73], thereby enhancing hyperphosphatemia and overt hyperparathyroidism, conditions at high risk for CVD.